4.6 Article

A one-stop approach to diagnosing hereditary colorectal cancer in the Chinese population

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients

Xi Chen et al.

Summary: This study confirmed the feasibility of using large panels to estimate TMB and demonstrated that bTMB can serve as a potential biomarker for predicting the efficacy of ICIs in NSCLC. Patients with higher TMB values had superior progression-free survival, indicating the potential of TMB as a predictive biomarker for immunotherapy efficacy.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Gastroenterology & Hepatology

Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair

Toky Ratovomanana et al.

Summary: This study evaluated the performance of NGS in identifying MSI in CRC, especially dMMR mCRC treated with ICI, and proposed a new algorithm called MSICare. The results showed that MSICare performed more accurately in detecting MSI in all testing modes, making it a potential reference method for NGS-based testing of MSI in CRC, especially in mCRC requiring ICI treatment.

GASTROENTEROLOGY (2021)

Article Oncology

Cytoplasmic MSH2 Related to Genomic Deletions in the MSH2/EPCAM Genes in Colorectal Cancer Patients With Suspected Lynch Syndrome

Lin Dong et al.

Summary: This study identified rare cytoplasmic MSH2 staining in CRC patients, some of whom had LS with pathogenic mutations in MSH2 and/or EPCAM, including large genomic rearrangements. Analysis revealed novel RNA fusions and deletions of EPCAM and MSH2, originating from Alu repeat-mediated recombination events. Clinical evidence supported the beneficial effect of PD-1 inhibitor pembrolizumab in CRC patients with cytoplasmic MSH2 staining.

FRONTIERS IN ONCOLOGY (2021)

Article Genetics & Heredity

Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)

Rong Mao et al.

Summary: Colorectal cancer has a familial component, with Lynch syndrome being the most common hereditary CRC syndrome. Using a multigene panel testing approach with NGS is an effective way to diagnose these conditions.

GENETICS IN MEDICINE (2021)

Article Oncology

Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study

Mengyuan Yang et al.

Summary: This multicenter study established a novel screening model based on clinical characteristics differences between Lynch syndrome and non-Lynch-associated dMMR in colorectal cancer patients. The model showed higher specificity and sensitivity than current screening criteria, with external validation confirming its universal applicability. Patients with a probability of LS greater than 0.435 are recommended for further germline sequencing.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Declining detection rates for APC and biallelic MUTYH variants in polyposis patients, implications for DNA testing policy

Diantha Terlouw et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

Article Oncology

Colorectal Cancer Screening, Version 2.2020 Featured Updates to the NCCN Guidelines

Dawn Provenzale et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Article Oncology

Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019 Featured Updates to the NCCN Guidelines

Samir Gupta et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Review Oncology

Lynch syndrome - cancer pathways, heterogeneity and immune escape

Sidhant Seth et al.

JOURNAL OF PATHOLOGY (2018)

Review Gastroenterology & Hepatology

Clinical management of hereditary colorectal cancer syndromes

Hans F. A. Vasen et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)

Article Biochemical Research Methods

MSIsensor: microsatellite instability detection using paired tumor-normal sequence data

Beifang Niu et al.

BIOINFORMATICS (2014)

Article Multidisciplinary Sciences

Comprehensive molecular characterization of gastric adenocarcinoma

Adam J. Bass et al.

NATURE (2014)

Editorial Material Oncology

EPCAM deletions, Lynch syndrome, and cancer risk

Henry T. Lynch et al.

LANCET ONCOLOGY (2011)